Floatz logo

Therapeutic Asset Ratings

3,229 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Droxidopa
Parkinson Disease
Loma Linda UniversityP4BB (66)
Elranatamab
Plasma Cell Myeloma
Anne Louise Tølbøll SørensenP4BB (66)
Empagliflozin
Atrial Fibrillation
Ali AminianP4BB (66)
Empagliflozin
Heart Failure
Jacob MollerP4BB (66)
Enoxaparin
Thrombotic Disease
Helsinki University Central HospitalP4BB (66)
Etoposide
B-Cell Non-Hodgkin Lymphoma
University of WashingtonP4BB (66)
Everolimus
Kidney Angiomyolipoma
Novartis PharmaceuticalsP4BB (66)
Febuxostat
Metabolic Dysfunction-Associated Steatotic Liver Disease
Ain Shams UniversityP4BB (66)
Fludarabine
Large B-Cell Lymphoma
M.D. Anderson Cancer CenterP4BB (66)
Fludarabine
Plasma Cell Myeloma
Fred Hutchinson Cancer CenterP4BB (66)
(±)-Ftc
Fatty Liver Disease
Fundacion SEIMC-GESIDAP4BB (66)
Fulvestrant
Breast Neoplasm
Eli Lilly and CompanyP4BB (66)
Fulvestrant
Her2-Receptor Negative Breast Cancer
Olema Pharmaceuticals, Inc.P4BB (66)
Fulvestrant
Metastatic Neoplasm
Eli Lilly and CompanyP4BB (66)
Ginkgo Biloba Extract
Alzheimer Disease
Hanyang UniversityP4BB (66)
Glucagon
Type 2 Diabetes Mellitus
Rutgers, The State University of New JerseyP4BB (66)
Goserelin
Metastatic Prostate Carcinoma
The First Affiliated Hospital of Xiamen UniversityP4BB (66)
Goserelin
Prostate Neoplasm
Novartis PharmaceuticalsP4BB (66)
Human Urinary Kallidinogenase
Ischemic Stroke
China-Japan Union HospitalP4BB (66)
Hyaluronate
Chronic Pain Syndrome
Sverdlovsk Regional Clinical Hospital No.1P4BB (66)
Hydromorphon
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer CenterP4BB (66)
Ibrutinib
B-Cell Non-Hodgkin Lymphoma
Oncternal Therapeutics, IncP4BB (66)
Ibrutinib
Non-Hodgkin Lymphoma
Yazeed SawalhaP4BB (66)
Inetetamab
Breast Cancer
Fudan UniversityP4BB (66)
Irinotecan
Her2-Receptor Negative Breast Cancer
GI Innovation, Inc.P4BB (66)
Showing 1576 to 1600 of 3,229 assets
PreviousPage 64 of 130Next